Deferasirox‐associated Fanconi syndrome in adult patients with transfusional iron overload
Sign Up to like & getrecommendations! Published in 2021 at "Vox Sanguinis"
DOI: 10.1111/vox.13064
Abstract: Deferasirox is an oral chelator approved for iron overload, which has a potential side effect of renal Fanconi syndrome, with proximal tubular dysfunction and tubular acidosis. Monitoring of renal function is recommended, though no standard… read more here.
Keywords: deferasirox associated; iron overload; associated fanconi; fanconi syndrome ... See more keywords